Clinical Trials Logo
  1. Home
  2. Trauma
  3. NCT03664063
  4. Details
NCT03664063 Clinical Trial

PK PD Study of IDA and Azithromycin for NTDs ( ComboNTDs )

Trauma Clinical Trial

Official title:
A Pharmacokinetic and Pharmacodynamic Evaluation of Co-Administration of IDA (Ivermectin, Diethylcarbamazine and Albendazole) & Azithromycin for Integrated Treatment of Neglected Tropical Diseases

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03664063
Other study ID # ComboNTDs-PK
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date September 1, 2018
Est. completion date January 1, 2019

Study information
Verified date February 2019
Source Lihir Medical Centre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a Pharmacokinetic and Pharmacodynamic study evaluating the safety of co-administering Azithromycin alongside the new IDA (Ivermectin, Diethylcarbamazine, Albendazole) combination treatment for LF. Individuals will be randomised to receive Azithromycin alone, IDA or combination therapy. Clinical and biochemical monitoring for safety will be undertaken. Drug levels will be measured in each of the three arms to assess whether combination therapy significantly alters drug levels.

Recruitment information / eligibility
Status Completed
Enrollment 42
Est. completion date January 1, 2019
Est. primary completion date October 1, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Adult aged 18-65

- Able to give informed consent

Exclusion Criteria:

- Known chronic illness

- Hb <7 at baseline

- Liver function or Creatinine * 1.5 Upper Limit of Normal

- Urinary tract infection at baseline

- Pregnancy (female participants only)

- Routine medications which interact with study drugs

- Lactose/Gluten intolerance

- Permanent disability impeding study participation

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Azithromycin
Treatment with Azithromycin single dose - weight based dosing max 2gm
• Albendazole
Single dose of Albendazole weight based dosing - 400mg
• Ivermectin
Ivermectin weight based dosing - max 21mg
• Diethylcarbamazine
Diethylcarbamazine weight based dosing - max 500mg

Locations
Country Name City State
Papua New Guinea Lihir Medical Centre Londolovit New Ireland Province

Sponsors (1)
Lead Sponsor Collaborator
Lihir Medical Centre

Country where clinical trial is conducted

Papua New Guinea, 

Outcome
Type Measure Description Time frame Safety issue
Primary Drug levels of Azithromycin, Ivermectin, Diethylcarbamazine, Albendazole Plasma concentrations of Azithromycin, Ivermectin, Diethylcarbamize, Albendazole 4 Days
Secondary Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 Patients will undergo regular monitoring for the duration of the study - adverse events will be graded from 1 to 4 in line with the CTCAE v4.0 Four days
See also
  Status Clinical Trial Phase
Recruiting NCT04848376 - Post-Market Clinical Follow-up Study of A-SPINE's Products
Terminated NCT03781817 - Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures Phase 4
Completed NCT04342416 - Using a Brief Visuospatial Interference Intervention to Reduce Intrusive Memories Among Trauma Exposed Women N/A
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Completed NCT05669313 - The Effects of Hypothermia and Acidosis on Coagulation During Treatment With Rivaroxaban Measured With ROTEM
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Recruiting NCT04725721 - Testing FIRST in Youth Outpatient Psychotherapy N/A
Active, not recruiting NCT05530642 - An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Not yet recruiting NCT03696563 - FreeO2 PreHospital - Automated Oxygen Titration vs Manual Titration According to the BLS-PCS N/A
Withdrawn NCT03249129 - Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Completed NCT02240732 - Surgical Tourniquets and Cerebral Emboli N/A
Completed NCT02227979 - Effects of PURPLE Cry Intervention N/A
Withdrawn NCT01169025 - Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients N/A
Recruiting NCT01812941 - Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients N/A
Completed NCT01475344 - Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC) Phase 1/Phase 2
Completed NCT03112304 - Child STEPS for Youth Mental Health in Maine Sustainability N/A
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Completed NCT01201863 - Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy Phase 4